| MeSH term | MeSH ID | Detail |
|---|---|---|
| Hypertension, Portal | D006975 | 12 associated lipids |
| Hypotension | D007022 | 41 associated lipids |
| Hypothermia | D007035 | 19 associated lipids |
| Inflammation | D007249 | 119 associated lipids |
| Insulin Resistance | D007333 | 99 associated lipids |
| Intestinal Pseudo-Obstruction | D007418 | 5 associated lipids |
| Learning Disorders | D007859 | 11 associated lipids |
| Liver Cirrhosis | D008103 | 67 associated lipids |
| Melanoma | D008545 | 69 associated lipids |
| Memory Disorders | D008569 | 33 associated lipids |
Anandamide
Anandamide is a lipid of Fatty Acyls (FA) class. Anandamide is associated with abnormalities such as Dehydration. The involved functions are known as Process, Phenomenon, Phosphorylation, Catabolic Process and Gene Expression. Anandamide often locates in Nuchal region, Microglial and Hepatic. The associated genes with Anandamide are SGPL1 gene, SPTLC1 gene, RPSA gene, KDSR gene and SMPD1 gene. The related lipids are Sphingolipids, Lipopolysaccharides, Lysophospholipids, LYSO-PC and lysophosphatidylethanolamine.
Cross Reference
Introduction
To understand associated biological information of Anandamide, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.
What diseases are associated with Anandamide?
Anandamide is suspected in Dehydration and other diseases in descending order of the highest number of associated sentences.
Related references are mostly published in these journals:
| Disease | Cross reference | Weighted score | Related literature |
|---|
Loading... please refresh the page if content is not showing up.
Possible diseases from mapped MeSH terms on references
We collected disease MeSH terms mapped to the references associated with Anandamide
PubChem Associated disorders and diseases
What pathways are associated with Anandamide
There are no associated biomedical information in the current reference collection.
PubChem Biomolecular Interactions and Pathways
Link to PubChem Biomolecular Interactions and PathwaysWhat cellular locations are associated with Anandamide?
Visualization in cellular structure
Associated locations are in red color. Not associated locations are in black.
Related references are published most in these journals:
| Location | Cross reference | Weighted score | Related literatures |
|---|
Loading... please refresh the page if content is not showing up.
What functions are associated with Anandamide?
Related references are published most in these journals:
| Function | Cross reference | Weighted score | Related literatures |
|---|
What lipids are associated with Anandamide?
Related references are published most in these journals:
| Lipid concept | Cross reference | Weighted score | Related literatures |
|---|
Loading... please refresh the page if content is not showing up.
What genes are associated with Anandamide?
Related references are published most in these journals:
| Gene | Cross reference | Weighted score | Related literatures |
|---|
What common seen animal models are associated with Anandamide?
There are no associated biomedical information in the current reference collection.
NCBI Entrez Crosslinks
All references with Anandamide
Download all related citations| Authors | Title | Published | Journal | PubMed Link |
|---|---|---|---|---|
| Ralevic V et al. | Cannabinoid activation of recombinant and endogenous vanilloid receptors. | 2001 | Eur. J. Pharmacol. | pmid:11672565 |
| Christopoulos A and Wilson K | Interaction of anandamide with the M(1) and M(4) muscarinic acetylcholine receptors. | 2001 | Brain Res. | pmid:11578621 |
| Fowler CJ et al. | Fatty acid amide hydrolase: biochemistry, pharmacology, and therapeutic possibilities for an enzyme hydrolyzing anandamide, 2-arachidonoylglycerol, palmitoylethanolamide, and oleamide. | 2001 | Biochem. Pharmacol. | pmid:11585048 |
| Izzo AA et al. | Effect of vanilloid drugs on gastrointestinal transit in mice. | 2001 | Br. J. Pharmacol. | pmid:11264233 |
| Baker D et al. | Endocannabinoids control spasticity in a multiple sclerosis model. | 2001 | FASEB J. | pmid:11156943 |
| Gauldie SD et al. | Anandamide activates peripheral nociceptors in normal and arthritic rat knee joints. | 2001 | Br. J. Pharmacol. | pmid:11159713 |
| Mang CF et al. | Differential effects of anandamide on acetylcholine release in the guinea-pig ileum mediated via vanilloid and non-CB1 cannabinoid receptors. | 2001 | Br. J. Pharmacol. | pmid:11522608 |
| Bradbury J | Small part of cannabis puzzle solved by animal studies. | 2001 | Lancet | pmid:11498223 |
| Jonsson KO et al. | Effects of homologues and analogues of palmitoylethanolamide upon the inactivation of the endocannabinoid anandamide. | 2001 | Br. J. Pharmacol. | pmid:11498512 |
| Hayase T et al. | Protective effects of cannabinoid receptor ligands analogous to anandamide against cocaine toxicity. | 2001 | Nihon Arukoru Yakubutsu Igakkai Zasshi | pmid:11828716 |
| Bueb JL et al. | Receptor-independent effects of natural cannabinoids in rat peritoneal mast cells in vitro. | 2001 | Biochim. Biophys. Acta | pmid:11336796 |
| Kim D and Thayer SA | Cannabinoids inhibit the formation of new synapses between hippocampal neurons in culture. | 2001 | J. Neurosci. | pmid:11319244 |
| Kagota S et al. | 2-Arachidonoylglycerol, a candidate of endothelium-derived hyperpolarizing factor. | 2001 | Eur. J. Pharmacol. | pmid:11275004 |
| Bisogno T et al. | The uptake by cells of 2-arachidonoylglycerol, an endogenous agonist of cannabinoid receptors. | 2001 | Eur. J. Biochem. | pmid:11277920 |
| De Petrocellis L et al. | The activity of anandamide at vanilloid VR1 receptors requires facilitated transport across the cell membrane and is limited by intracellular metabolism. | 2001 | J. Biol. Chem. | pmid:11278420 |
| Wallace MJ et al. | Evidence for a physiological role of endocannabinoids in the modulation of seizure threshold and severity. | 2002 | Eur. J. Pharmacol. | pmid:12359270 |
| Roberts LA et al. | Anandamide is a partial agonist at native vanilloid receptors in acutely isolated mouse trigeminal sensory neurons. | 2002 | Br. J. Pharmacol. | pmid:12359623 |
| Oz M et al. | Endogenous cannabinoid, anandamide, acts as a noncompetitive inhibitor on 5-HT3 receptor-mediated responses in Xenopus oocytes. | 2002 | Synapse | pmid:12325042 |
| Ralevic V et al. | Cannabinoid modulation of sensory neurotransmission via cannabinoid and vanilloid receptors: roles in regulation of cardiovascular function. | 2002 | Life Sci. | pmid:12354577 |
| Laine K et al. | Comparison of the enzymatic stability and intraocular pressure effects of 2-arachidonylglycerol and noladin ether, a novel putative endocannabinoid. | 2002 | Invest. Ophthalmol. Vis. Sci. | pmid:12356827 |
| Barthó L et al. | Nitric oxide is involved in the relaxant effect of capsaicin in the human sigmoid colon circular muscle. | 2002 | Naunyn Schmiedebergs Arch. Pharmacol. | pmid:12382081 |
| Milton NG | Anandamide and noladin ether prevent neurotoxicity of the human amyloid-beta peptide. | 2002 | Neurosci. Lett. | pmid:12384227 |
| Darmani NA | The potent emetogenic effects of the endocannabinoid, 2-AG (2-arachidonoylglycerol) are blocked by delta(9)-tetrahydrocannabinol and other cannnabinoids. | 2002 | J. Pharmacol. Exp. Ther. | pmid:11752094 |
| Krylatov AV et al. | Endogenous cannabinoids improve myocardial resistance to arrhythmogenic effects of coronary occlusion and reperfusion: a possible mechanism. | 2002 | Bull. Exp. Biol. Med. | pmid:12428277 |
| Plant LD et al. | Hypoxic depolarization of cerebellar granule neurons by specific inhibition of TASK-1. | 2002 | Stroke | pmid:12215606 |
| Molina-Holgado F et al. | Role of CB1 and CB2 receptors in the inhibitory effects of cannabinoids on lipopolysaccharide-induced nitric oxide release in astrocyte cultures. | 2002 | J. Neurosci. Res. | pmid:11891798 |
| Ford WR et al. | Evidence of a novel site mediating anandamide-induced negative inotropic and coronary vasodilatator responses in rat isolated hearts. | 2002 | Br. J. Pharmacol. | pmid:11877326 |
| Harris D et al. | Characterization of vasorelaxant responses to anandamide in the rat mesenteric arterial bed. | 2002 | J. Physiol. (Lond.) | pmid:11897858 |
| Lin YS and Lee LY | Stimulation of pulmonary vagal C-fibres by anandamide in anaesthetized rats: role of vanilloid type 1 receptors. | 2002 | J. Physiol. (Lond.) | pmid:11897863 |
| Walter L et al. | Astrocytes in culture produce anandamide and other acylethanolamides. | 2002 | J. Biol. Chem. | pmid:11916961 |
| Begg M et al. | Modulation of the release of endogenous gamma-aminobutyric acid by cannabinoids in the guinea pig ileum. | 2002 | Eur. J. Pharmacol. | pmid:11755170 |
| Ros J et al. | Endogenous cannabinoids: a new system involved in the homeostasis of arterial pressure in experimental cirrhosis in the rat. | 2002 | Gastroenterology | pmid:11781284 |
| Lever IJ and Malcangio M | CB(1) receptor antagonist SR141716A increases capsaicin-evoked release of Substance P from the adult mouse spinal cord. | 2002 | Br. J. Pharmacol. | pmid:11786475 |
| Liu WM et al. | Effects of anandamide on embryo implantation in the mouse. | 2002 | Life Sci. | pmid:12137909 |
| Di Marzo V et al. | Endovanilloid signaling in pain. | 2002 | Curr. Opin. Neurobiol. | pmid:12139983 |
| Matias I et al. | Presence and regulation of the endocannabinoid system in human dendritic cells. | 2002 | Eur. J. Biochem. | pmid:12153574 |
| Schäbitz WR et al. | Release of fatty acid amides in a patient with hemispheric stroke: a microdialysis study. | 2002 | Stroke | pmid:12154273 |
| Costa B et al. | Chronic treatment with the endocannabinoid anandamide increases cytochrome P450 metabolizing system in the rat. | 2002 | Eur. J. Pharmacol. | pmid:12163107 |
| de Lago E et al. | UCM707, a potent and selective inhibitor of endocannabinoid uptake, potentiates hypokinetic and antinociceptive effects of anandamide. | 2002 | Eur. J. Pharmacol. | pmid:12163112 |
| Andersson DA et al. | Mechanisms underlying tissue selectivity of anandamide and other vanilloid receptor agonists. | 2002 | Mol. Pharmacol. | pmid:12181448 |
| Chemin J et al. | Neuronal T-type alpha 1H calcium channels induce neuritogenesis and expression of high-voltage-activated calcium channels in the NG108-15 cell line. | 2002 | J. Neurosci. | pmid:12177183 |
| Goutopoulos A and Makriyannis A | From cannabis to cannabinergics: new therapeutic opportunities. | 2002 | Pharmacol. Ther. | pmid:12182958 |
| Gubellini P et al. | Experimental parkinsonism alters endocannabinoid degradation: implications for striatal glutamatergic transmission. | 2002 | J. Neurosci. | pmid:12177188 |
| Hansen HS et al. | Putative neuroprotective actions of N-acyl-ethanolamines. | 2002 | Pharmacol. Ther. | pmid:12182959 |
| Randall MD et al. | Cardiovascular effects of cannabinoids. | 2002 | Pharmacol. Ther. | pmid:12182966 |
| Kagaya M et al. | Characterization of the anandamide induced depolarization of guinea-pig isolated vagus nerve. | 2002 | Br. J. Pharmacol. | pmid:12183329 |
| Gardiner SM et al. | Complex regional haemodynamic effects of anandamide in conscious rats. | 2002 | Br. J. Pharmacol. | pmid:11959791 |
| Jerman JC et al. | Comparison of effects of anandamide at recombinant and endogenous rat vanilloid receptors. | 2002 | Br J Anaesth | pmid:12453933 |
| Jia Y et al. | Anandamide induces cough in conscious guinea-pigs through VR1 receptors. | 2002 | Br. J. Pharmacol. | pmid:12411414 |
| Geraghty DP and Mazzone SB | Respiratory actions of vanilloid receptor agonists in the nucleus of the solitary tract: comparison of resiniferatoxin with non-pungent agents and anandamide. | 2002 | Br. J. Pharmacol. | pmid:12411424 |